CID HoldCo Inc
NASDAQ:DAIC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CID HoldCo Inc
NASDAQ:DAIC
|
US |
|
A
|
Arrivent Biopharma Inc
NASDAQ:AVBP
|
US |
|
S
|
Saipem SpA
OTC:SAPMF
|
IT |
|
Vaibhav Global Ltd
NSE:VAIBHAVGBL
|
IN |
Balance Sheet
Balance Sheet Decomposition
CID HoldCo Inc
CID HoldCo Inc
Balance Sheet
CID HoldCo Inc
| Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
1
|
|
| Cash |
0
|
0
|
0
|
1
|
|
| Total Receivables |
0
|
0
|
0
|
4
|
|
| Accounts Receivables |
0
|
0
|
0
|
4
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
1
|
1
|
6
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
1
|
2
|
3
|
|
| Long-Term Investments |
310
|
21
|
6
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
2
+42%
|
3
+83%
|
11
+245%
|
|
| Liabilities | |||||
| Accounts Payable |
0
|
0
|
1
|
4
|
|
| Accrued Liabilities |
0
|
0
|
0
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
2
|
|
| Other Current Liabilities |
0
|
0
|
1
|
0
|
|
| Total Current Liabilities |
0
|
0
|
2
|
8
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
|
| Other Liabilities |
2
|
5
|
25
|
2
|
|
| Total Liabilities |
2
N/A
|
5
+105%
|
27
+489%
|
10
-62%
|
|
| Equity | |||||
| Common Stock |
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1
|
3
|
25
|
61
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
62
|
|
| Other Equity |
1
|
1
|
1
|
0
|
|
| Total Equity |
1
N/A
|
3
-175%
|
24
-723%
|
0
N/A
|
|
| Total Liabilities & Equity |
1
N/A
|
2
+42%
|
3
+83%
|
11
+245%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
28
|
28
|
28
|
29
|
|